The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Multi-functional polymeric nanoparticles for tumour-targeted drug delivery
Abstract
The use of nanoparticles as drug delivery vehicles for anticancer therapeutics has great potential to revolutionise the future of cancer therapy. As tumour architecture causes nanoparticles to preferentially accumulate at the tumour site, their use as drug delivery vectors results in the localisation of a greater amount of the drug load at the tumour site; thus improving cancer therapy and reducing the harmful nonspecific side effects of chemotherapeutics. In addition, formulation of these nanoparticles with imaging contrast agents provides a very efficient system for cancer diagnostics. Given the exhaustive possibilities available to polymeric nanoparticle chemistry, research has quickly been directed at multi-functional nanoparticles, combining tumour targeting, tumour therapy and tumour imaging in an all-in-one system, providing a useful multi-modal approach in the battle against cancer. This review will discuss the properties of nanoparticles that allow for such multiple functionality, as well as recent scientific advances in the area of multi-functional nanoparticles for cancer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. B., Norris, D. J., & Bawendi, M. G. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00072a025 · Cited by 9,282
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · cited 1×
“Due to the rapid growth of solid tumours, many tumours present with fenestrated vasculature and poor lymphatic drainage, resulting in an enhanced permeability and retention (EPR) effect [5], which allows nanoparticles to accumulate specifically at the tumour site (Figure 1).”
BackgroundQuantum dot bioconjugates for imaging, labelling and sensing
Medintz, I. L., Uyeda, H. T., Goldman, E. R., & Mattoussi, H. (2005) · Nature Materials · doi:10.1038/nmat1390 · Cited by 6,229
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,772
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, J. D., Halas, N. J., & West, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232479100 · Cited by 3,955
A clearer vision for in vivo imaging
Weissleder, R. (2001) · Nature Biotechnology · doi:10.1038/86684 · Cited by 3,839
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Polymeric systems for controlled drug release
Uhrich, K. E., Cannizzaro, S. M., Langer, R. S., & Shakesheff, K. M. (1999) · Chemical Reviews · doi:10.1021/cr940351u · Cited by 2,633
Wu, X., Liu, H., Liu, J., Haley, K. N., Treadway, J. A., Larson, J. P., Ge, N., Peale, F., & Bruchez, M. P. (2003) · Nature Biotechnology · doi:10.1038/nbt764 · Cited by 2,506
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Luminescent quantum dots for multiplexed biological detection and imaging
Chan, W. C. W., Maxwell, D. J., Gao, X., Bailey, R. E., Han, M., & Nie, S. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00282-3 · Cited by 2,068
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
El-Sayed, I. H., Huang, X., & El-Sayed, M. A. (2005) · Nano Letters · doi:10.1021/nl050074e · Cited by 1,919
Immunotargeted Nanoshells for Integrated Cancer Imaging and Therapy
Loo, C., Lowery, A., Halas, N., West, J., & Drezek, R. (2005) · Nano Letters · doi:10.1021/nl050127s · Cited by 1,792
The use of gold nanoparticles to enhance radiotherapy in mice
Hainfeld, J. F., Slatkin, D. N., & Smilowitz, H. M. (2004) · Physics in Medicine and Biology · doi:10.1088/0031-9155/49/18/n03 · Cited by 1,638
In vivo molecular and cellular imaging with quantum dots
Gao, X., Yang, L., Petros, J. A., Marshall, F. F., Simons, J. W., & Nie, S. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.11.003 · Cited by 1,211
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery
Paciotti, G. F., Myer, L., Weinreich, D., Goia, D., Pavel, N., McLaughlin, R. E., & Tamarkin, L. (2004) · Drug Delivery · doi:10.1080/10717540490433895 · Cited by 1,185
Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer
Loo, C., Lin, A., Hirsch, L., Lee, M.-H., Barton, J., Halas, N., West, J., & Drezek, R. (2004) · Technology in Cancer Research & Treatment · doi:10.1177/153303460400300104 · Cited by 1,160
Gold Nanocages: Bioconjugation and Their Potential Use as Optical Imaging Contrast Agents
Chen, J., Saeki, F., Wiley, B. J., Cang, H., Cobb, M. J., Li, Z.-Y., Au, L., Zhang, H., Kimmey, M. B., Li, X., et al. (2005) · Nano Letters · doi:10.1021/nl047950t · Cited by 977
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 945
Thomas, H., & Coley, H. M. (2003) · Cancer Control · doi:10.1177/107327480301000207 · Cited by 931
Iron Oxide Nanoparticles for Sustained Delivery of Anticancer Agents
Jain, T. K., Morales, M. A., Sahoo, S. K., Leslie-Pelecky, D. L., & Labhasetwar, V. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0500014 · Cited by 904
Light-absorbing properties, stability, and spectral stabilization of indocyanine green
Landsman, M. L., Kwant, G., Mook, G. A., & Zijlstra, W. G. (1976) · Journal of Applied Physiology · doi:10.1152/jappl.1976.40.4.575 · Cited by 834
Fonseca, C., Simões, S., & Gaspar, R. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00212-2 · Cited by 755
Voura, E. B., Jaiswal, J. K., Mattoussi, H., & Simon, S. M. (2004) · Nature Medicine · doi:10.1038/nm1096 · Cited by 688
Kabbinavar, F. F., Hambleton, J., Mass, R. D., Hurwitz, H. I., Bergsland, E., & Sarkar, S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.232 · Cited by 686
Folate Receptor-Mediated Drug Targeting: From Therapeutics to Diagnostics
Hilgenbrink, A. R., & Low, P. S. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20457 · Cited by 625
Mechanism of multidrug resistance
Bradley, G., Juranka, P. F., & Ling, V. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90006-6 · Cited by 617
Kohler, N., Sun, C., Wang, J., & Zhang, M. (2005) · Langmuir · doi:10.1021/la0503451 · Cited by 579
Design of Folic Acid‐Conjugated Nanoparticles for Drug Targeting
Stella, B., Arpicco, S., Peracchia, M. T., Desmaële, D., Hoebeke, J., Renoir, M., D'Angelo, J., Cattel, L., & Couvreur, P. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1452::aid-jps8>3.0.co;2-p · Cited by 553
Infrared extinction properties of gold nanoshells
Oldenburg, S. J., Jackson, J. B., Westcott, S. L., & Halas, N. J. (1999) · Applied Physics Letters · doi:10.1063/1.125183 · Cited by 543
Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent
Zhao, M., Beauregard, D. A., Loizou, L., Davletov, B., & Brindle, K. M. (2001) · Nature Medicine · doi:10.1038/nm1101-1241 · Cited by 521
Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen
Chawla, J. S., & Amiji, M. M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00483-0 · Cited by 487
Self-citationRegulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance
Reed, J. C. (1995) · Current Opinion in ONCOLOGY · doi:10.1097/00001622-199511000-00012 · Cited by 479
Antiangiogenic Properties of Gold Nanoparticles
Mukherjee, P., Bhattacharya, R., Wang, P., Wang, L., Basu, S., Nagy, J. A., Atala, A., Mukhopadhyay, D., & Soker, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2482 · Cited by 468
Chouly, C., Pouliquen, D., Lucet, I., Jeune, J. J., & Jallet, P. (1996) · Journal of Microencapsulation · doi:10.3109/02652049609026013 · Cited by 467
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
Tran, J., Master, Z., Yu, J. L., Rak, J., Dumont, D. J., & Kerbel, R. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072586399 · Cited by 434
Magnetic Polystyrene Nanoparticles with a High Magnetite Content Obtained by Miniemulsion Processes
Ramírez, L. P., & Landfester, K. (2003) · Macromolecular Chemistry and Physics · doi:10.1002/macp.200290052 · Cited by 403
Lynn, D. M., Anderson, D. G., Putnam, D., & Langer, R. (2001) · Journal of the American Chemical Society · doi:10.1021/ja016288p · Cited by 393
Quantum dots as photosensitizers?
Bakalova, R., Ohba, H., Zhelev, Z., Ishikawa, M., & Baba, Y. (2004) · Nature Biotechnology · doi:10.1038/nbt1104-1360 · Cited by 381
Akinc, A., Lynn, D. M., Anderson, D. G., & Langer, R. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034429c · Cited by 376
Biocompatible fluorescent nanocrystals for immunolabeling of membrane proteins and cells
Sukhanova, A., Devy, J., Venteo, L., Kaplan, H., Artemyev, M., Oleinikov, V., Klinov, D., Pluot, M., Cohen, J. H. M., & Nabiev, I. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2003.09.031 · Cited by 323
Glutathione S-transferases and drug resistance
(1991) · International Journal of Biochemistry · doi:10.1016/0020-711x(91)90023-g · Cited by 305
Oyewumi, M. O., Yokel, R. A., Jay, M., Coakley, T., & Mumper, R. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.002 · Cited by 296
Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles
Vauthier, C. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.005 · Cited by 283
Long-Circulating Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles for Intracellular Delivery
Kaul, G., & Amiji, M. (2002) · Pharmaceutical Research · doi:10.1023/a:1016486910719 · Cited by 281
Self-citationEmilienne Soma, C., Dubernet, C., Bentolila, D., Benita, S., & Couvreur, P. (2000) · Biomaterials · doi:10.1016/s0142-9612(99)00125-8 · Cited by 281
Defective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy
Altan, N., Chen, Y., Schindler, M., & Simon, S. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1583 · Cited by 265
Future directions of liposome- and immunoliposome-based cancer therapeutics
Park, J. W., Benz, C. C., & Martin, F. J. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.009 · Cited by 240
Synthesis and Characterization of Spherical Magnetite/Biodegradable Polymer Composite Particles
Gómez-Lopera, S. A., Plaza, R. C., & Delgado, A. V. (2001) · Journal of Colloid and Interface Science · doi:10.1006/jcis.2001.7579 · Cited by 227
Folate-Mediated Targeting of Therapeutic and Imaging Agents to Cancers
Reddy, J. A., & Low, P. S. (1998) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v15.i6.20 · Cited by 219
Ito, A., Tanaka, K., Kondo, K., Shinkai, M., Honda, H., Matsumoto, K., Saida, T., & Kobayashi, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01438.x · Cited by 216
Clinical trials of p-glycoprotein reversal in solid tumours
Ferry, D. R., Traunecker, H., & Kerr, D. J. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00091-3 · Cited by 214
Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells
Wartlick, H., Michaelis, K., Balthasar, S., Strebhardt, K., Kreuter, J., & Langer, K. (2004) · Journal of Drug Targeting · doi:10.1080/10611860400010697 · Cited by 211
Mechanisms of Multidrug Resistance in Cancer Treatment
Harris, A. L., & Hochhauser, D. (1992) · Acta Oncologica · doi:10.3109/02841869209088904 · Cited by 207
Size dependent magnetic properties of iron oxide nanoparticles
Chatterjee, J., Haik, Y., & Chen, C.-J. (2003) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(02)01066-1 · Cited by 206
Potineni, A., Lynn, D. M., Langer, R., & Amiji, M. M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00374-7 · Cited by 201
Self-citationSynthesis and Characterization of Soluble Iron Oxide−Dendrimer Composites
Strable, E., Bulte, J. W. M., Moskowitz, B., Vivekanandan, K., Allen, M., & Douglas, T. (2001) · Chemistry of Materials · doi:10.1021/cm010125i · Cited by 192
Itô, A., Shinkai, M., Honda, H., et al. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700357 · Cited by 151
Zhang, Y., & Zhang, J. (2004) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2004.09.042 · Cited by 150
Tokumitsu, H., Hiratsuka, J., Sakurai, Y., Kobayashi, T., Ichikawa, H., & Fukumori, Y. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00388-2 · Cited by 140
Shikata, F., Tokumitsu, H., Ichikawa, H., & Fukumori, Y. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00198-9 · Cited by 122
Mechanisms of Multidrug Resistance
Kellen, J. A. (1995) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-9852-7_1 · Cited by 117
Tuettenberg, J., Grobholz, R., Korn, T., Wenz, F. K., Erber, R., & Vajkoczy, P. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0620-5 · Cited by 114
Targeting Cells with MR Imaging Probes Based on Paramagnetic Gd(III) Chelates
Aime, S., Barge, A., Cabella, C., Crich, S. G., & Gianolio, E. (2004) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201043376580 · Cited by 104
Shinkai, M., Suzuki, M., Iijima, S., & Kobayashi, T. (1995) · Biotechnology and Applied Biochemistry · doi:10.1111/j.1470-8744.1995.tb00329.x · Cited by 103
Nsereko, S., & Amiji, M. M. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00005-4 · Cited by 98
Self-citationMorel, S., Terreno, E., Ugazio, E., Aime, S., & Gasco, M. R. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00107-0 · Cited by 97
Antiangiogenesis drug promising for metastatic colorectal cancer
McCarthy, M. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13603-3 · Cited by 94
Minamimura, T., Sato, H., Kasaoka, S., Saito, T., Ishizawa, S., Takemori, S., Tazawa, K., & Tsukada, K. (2000) · International Journal of Oncology · doi:10.3892/ijo.16.6.1153 · Cited by 90
Role of Thiamin (Vitamin B-1) and Transketolase in Tumor Cell Proliferation
Cascante, M., Centelles, J. J., Veech, R. L., Lee, W. P., & Boros, L. G. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc3602_2 · Cited by 87
Oyewumi, M. O., & Mumper, R. J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025560x · Cited by 80
Ma, L., Francia, G., Viloria‐Petit, A., Hicklin, D. J., du Manoir, J. M., Rak, J. W., & Kerbel, R. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3156 · Cited by 75
Review : Synthetic Polymers with Intrinsic Anticancer Activity
Seymour, L. (1991) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159100600205 · Cited by 53
Oyewumi, M. O., Liu, S., Moscow, J. A., et al. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0340013 · Cited by 49
Emanuel, S. L., Gruninger, R. H., Fuentes‐Pesquera, A. R., Connolly, P. J., Seamon, J. A., Hazel, S. J., Tominovich, R. M., Hollister, B. A., Napier, C., D’Andrea, M. R., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000638 · Cited by 41
The reversal of multidrug resistance: an update
Kellen, J. A. (2003) · Journal of Experimental Therapeutics and Oncology · doi:10.1046/j.1359-4117.2003.01067.x · Cited by 34
Raaphorst, G. P., Yang, H., Wilkins, D. E., et al. (1996) · International Journal of Hyperthermia · doi:10.3109/02656739609027686 · Cited by 14
Cited by
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Torchilin, V. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4333 · Cited by 1,663
Diverse Applications of Nanomedicine
Pelaz, B., Alexiou, C., Alvarez-Puebla, R. A., Alves, F., Andrews, A. M., Ashraf, S., Balogh, L. P., Ballerini, L., Bestetti, A., Brendel, C., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06040 · Cited by 1,350
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,112
Metadata
- Authors
- van Vlerken, L. E., & Amiji, M. M.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa Healthcare
- Published
- 2006-02-28
- Volume
- 3
- Issue
- 2
- Pages
- 205-216
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2018107016
- Cited by
- 352
- References
- 81
- FWCI
- 9.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.